- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07645053
Effects of Platelet-Rich Fibrin on Postoperative Outcomes Following Nasosinusal Surgery
EFEITOS DO USO DE FIBRINA RICA EM PLAQUETAS NO PÓS-OPERATÓRIO DE CIRURGIAS NASOSSINUSAIS
tudy Design This was a prospective, randomized, double-blind, controlled clinical trial designed to evaluate the effects of platelet-rich fibrin (PRF) on postoperative healing following partial inferior turbinectomy.
Patients undergoing surgery at the Centro de Otorrinolaringologia e Fonoaudiologia de São Paulo (COF) were allocated to either a PRF treatment group or a control group. Postoperative outcomes were assessed at 1 week and 1 month after surgery using a standardized evaluation protocol completed by blinded investigators.
Clinical parameters related to wound healing and postoperative recovery were recorded and subsequently compared between groups to determine the impact of PRF application on surgical outcomes.
연구 개요
상세 설명
## Methodology
This study was designed as a prospective, controlled, double-blind trial. Data were collected using a standardized clinical questionnaire completed by the attending physicians of patients undergoing sinonasal surgery at the Centro de Otorrinolaringologia e Fonoaudiologia de São Paulo (COF), São Paulo, Brazil. A specific data collection form was used to record postoperative clinical findings.
Study Procedures
- The study population consisted of patients undergoing sinonasal surgery at COF, who were evaluated at 1 week and 1 month postoperatively.
- Platelet-rich fibrin (PRF) was prepared intraoperatively through autologous blood collection followed by centrifugation in the operating room, requiring approximately 20 minutes.
- PRF membrane was randomly applied topically to one nasal cavity, while the contralateral cavity served as the control.
- At the end of the procedure, while the patient remained under general anesthesia, the PRF membrane was placed by the assisting surgeon without the presence of the attending surgeon in the operating room.
- Neither the attending surgeon responsible for postoperative evaluations nor the patient was aware of which nasal cavity had received PRF treatment.
- The questionnaire (Figure 1) was completed during routine postoperative visits at 1 week and 1 month following surgery, after otorhinolaryngological examination performed by the attending surgeon.
- The physician completed a separate evaluation form for each nasal cavity, allowing intra-patient comparison between treated and untreated sides.
- Confidentiality of patient records and questionnaire data was ensured through the signing of confidentiality and informed consent agreements by all participants.
- Collected data were organized in standardized databases. The study was conducted in accordance with the principles of the Declaration of Helsinki and Resolution No. 466/2012 of the Brazilian National Health Council regarding research involving human subjects.
- A database was created for each participant, including the following variables: descriptive nasal bleeding scale, descriptive crust formation scale, sex, age, and type of surgical procedure performed.
- Inclusion Criteria
Patients undergoing sinonasal surgery at the Centro de Otorrinolaringologia e Fonoaudiologia de São Paulo (COF), São Paulo, Brazil, were eligible for inclusion.
Confidentiality of medical records and questionnaire data was ensured through the execution of confidentiality agreements between study participants and the institution.
### Exclusion Criteria
Patients who declined participation or failed to sign the informed consent form were excluded.
Patients who did not attend either the 1-week or 1-month postoperative follow-up visits were also excluded.
## Statistical Methodology
### Sample Characteristics
The initial sample consisted of 18 patients, including 8 women and 10 men, aged between 25 and 43 years.
During the study period, 4 patients were excluded because they failed to attend the scheduled postoperative visits at either 1 week or 1 month. Consequently, the final sample comprised 14 patients, including 7 women and 7 men.
All surgical procedures included partial inferior turbinectomy (100%).
### Statistical Analysis
Exploratory data analysis included calculation of means, medians, standard deviations, and ranges for continuous variables, as well as frequencies and proportions for categorical variables.
The distribution of numerical variables was assessed using descriptive statistics, histograms, boxplots, and the Shapiro-Wilk test for normality.
Comparative analyses of outcomes between postoperative time points (1 week and 1 month) and treatment groups (PRF-treated versus control side) were performed using Rank-Based Analysis of Variance (Rank ANOVA) as described by Wobbrock et al. (2011).
Partial eta squared (η²ₚ) was calculated as a measure of effect size for the overall ANOVA model and interpreted according to conventional thresholds:
- η²ₚ = 0.01: small effect
- η²ₚ = 0.06: medium effect
- η²ₚ = 0.14: large effect
연구 유형
등록 (실제)
단계
- 2 단계
- 1단계
연락처 및 위치
연구 장소
-
-
São Paulo
-
São Paulo, São Paulo, 브라질, 04038-905
- Hospital Edmundo Vasconcelos
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Adults aged 18 years or older. Patients undergoing sinonasal surgery including partial inferior turbinectomy at the Centro de Otorrinolaringologia e Fonoaudiologia de São Paulo (COF).
Ability to provide written informed consent. Willingness to attend scheduled postoperative follow-up visits at 1 week and 1 month after surgery.
Exclusion Criteria:
- Refusal or inability to provide written informed consent. Failure to attend either the 1-week or the 1-month postoperative follow-up visit.
Incomplete postoperative evaluation data.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Split-Nose PRF vs Control
Each participant served as their own control.
Following partial inferior turbinectomy, platelet-rich fibrin (PRF) membrane was randomly applied to one nasal cavity, while the contralateral nasal cavity received no PRF treatment.
Postoperative outcomes, including nasal crusting and bleeding, were evaluated at 1 week and 1 month after surgery by blinded assessors.
|
Autologous platelet-rich fibrin (PRF) prepared intraoperatively from the participant's peripheral blood through a single-step centrifugation process.
The resulting fibrin membrane was applied topically to one randomly selected nasal cavity at the completion of partial inferior turbinectomy, while the contralateral nasal cavity served as an untreated control.
PRF contains a dense fibrin matrix enriched with platelets, leukocytes, cytokines, and growth factors that may promote mucosal healing and reduce postoperative crust formation.
Postoperative outcomes were assessed at 1 week and 1 month after surgery by blinded evaluators.
No intervention done in one side of the nasal cavity
|
|
위약 비교기: Split Nose vs. Control
Each participant served as their own control.
Following partial inferior turbinectomy, platelet-rich fibrin (PRF) membrane was randomly applied to one nasal cavity, while the contralateral nasal cavity received no PRF treatment.
Postoperative outcomes, including nasal crusting and bleeding, were evaluated at 1 week and 1 month after surgery by blinded assessors.
|
Autologous platelet-rich fibrin (PRF) prepared intraoperatively from the participant's peripheral blood through a single-step centrifugation process.
The resulting fibrin membrane was applied topically to one randomly selected nasal cavity at the completion of partial inferior turbinectomy, while the contralateral nasal cavity served as an untreated control.
PRF contains a dense fibrin matrix enriched with platelets, leukocytes, cytokines, and growth factors that may promote mucosal healing and reduce postoperative crust formation.
Postoperative outcomes were assessed at 1 week and 1 month after surgery by blinded evaluators.
No intervention done in one side of the nasal cavity
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Postoperative Nasal Crusting Score
기간: From enrollment to the end of treatment at 4 weeks
|
Comparison of postoperative nasal crust formation between PRF-treated and untreated nasal cavities following partial inferior turbinectomy.
Crusting severity was assessed using a physician-reported ordinal scale ranging from 1 (no crusting) to 4 (severe crusting).
Each patient served as their own control, with one nasal cavity randomly assigned to receive topical platelet-rich fibrin (PRF) and the contralateral cavity serving as an untreated control.
|
From enrollment to the end of treatment at 4 weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Postoperative Nasal Bleeding Score
기간: 1 week and 1 month after surgery
|
Comparison of postoperative nasal bleeding between PRF-treated and untreated nasal cavities following partial inferior turbinectomy.
Bleeding severity was assessed using a physician-reported ordinal scale ranging from 1 (no bleeding) to 4 (severe bleeding requiring surgical intervention).
Each patient served as their own control.
|
1 week and 1 month after surgery
|
공동 작업자 및 조사자
수사관
- 연구 책임자: Leonardo Bomediano Sousa Garcia
간행물 및 유용한 링크
일반 간행물
- Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e56-60. doi: 10.1016/j.tripleo.2005.07.011.
- Qin X, Sun Q, Chen G, Liu J, Gao T, Bai G, Guo Z. Risk factors for postoperative bleeding after endoscopic sinus surgery to treat chronic rhinosinusitis. Acta Otolaryngol. 2021 Apr;141(4):392-396. doi: 10.1080/00016489.2021.1878276. Epub 2021 Feb 13.
- Sharifi A, Kouhi A, Patel ZM. Utilization and efficacy of platelet-rich plasma and platelet-rich fibrin in otolaryngology: a systematic evidence-based review. Eur Arch Otorhinolaryngol. 2024 Oct;281(10):5091-5110. doi: 10.1007/s00405-024-08763-1. Epub 2024 Jun 24.
- Dinaki K, Grigoriadis N, Papadopoulos C, Vizirianakis I, Constantinidis J, Triaridis S, Karkos P. Platelet-Rich Fibrin in Otorhinolaryngology. Maedica (Bucur). 2023 Dec;18(4):672-678. doi: 10.26574/maedica.2023.18.4.672.
- 9. Vendramin FS, Franco D, Nogueira CM, Pereira MS, Franco TR. Plasma rico em plaquetas e fatores de crescimento: técina de preparo e utilização em cirurgia plástica. Ver. Col. Bras. Cir. 33(1); Fev, 2006.
- 8. Choukroun J, Adda F, Schoeffler C, Vervelle A. [An opportunity in paroimplantology: PRF.] Implantodontie. 2001;42(55):e62.
- Fioravanti C, Frustaci I, Armellin E, Condo R, Arcuri C, Cerroni L. Autologous blood preparations rich in platelets, fibrin and growth factors. Oral Implantol (Rome). 2016 Jul 23;8(4):96-113. doi: 10.11138/orl/2015.8.4.096. eCollection 2015 Oct-Dec.
- 5. Vieira, Fernando Mirage Jardim, et al. "Platelet Rich Fibrin (PRF): An Autologous Biomaterial for Turbinectomy Healing Assistance." American Journal of Otolaryngology and Head and Neck Surgery 6.1 (2018): 2-3.
- Lei X, Cheng L, Yang Y, Pang M, Dong Y, Zhu X, Chen C, Yao Z, Wu G, Cheng B, Forouzanfar T. Co-administration of platelet-rich plasma and small intestinal submucosa is more beneficial than their individual use in promoting acute skin wound healing. Burns Trauma. 2021 Nov 30;9:tkab033. doi: 10.1093/burnst/tkab033. eCollection 2021.
- 3. Aboelnaga, Heba Abdelreheem, et al. "Evaluation of the use of autologous platelet-rich fibrin in myringoplasty operation." The Egyptian Journal of Otolaryngology 38.1 (2022): 142.
- 2. Tratado de otorrinolaringologia / organizacao Shirley Shizue Nagata Pignatari, Wilma Terezinha Anselmo- Lima. 3. ed. Rio de Janeiro: Elsevier, 2018
- 1. Balsalobre L, Tepedino MS. Rinologia 360º: Aspectos Clínicos e Cirúrgicos. Thieme Revinter; Brasil, 2021
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 8229452400000090
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
비갑개 수술에 대한 임상 시험
-
Sinai UniversityMenoufia University완전한
-
Karolinska Institutet초대로 등록TMD | TMJ - 측두하악 관절의 반월판 손상 | TMJ- Oral & amp; Maxillofacial Surgery스웨덴
-
National Taiwan University Hospital초대로 등록소아과 | 폐외과 | 수술 후 빠른 회복(Enhanced Recovery After Surgery, ERAS)대만
-
Assistance Publique Hopitaux De Marseille완전한심혈관 질환 | 비만 환자 | Bariatric Surgery 전후의 이러한 TRL의 생성률프랑스
-
Dong Yang알려지지 않은복강경 보조 수술 | 절개 없는 복강경 전수술(Natural Orifice Transluminal Endoscopic Surgery, NOSES)중국
-
Near East University, TurkeyAl-Ahli Hospital, Hebron모집하지 않고 적극적으로DVT 예방 | DVT - 심부 정맥 혈전증 | 심장 온펌프 수술 | DVT 예방 | On-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - Complications | 간호 관리 프로토콜키프로스
-
University Hospital, Strasbourg, France모병Cervico-Facial Surgery ENT 프랑스의 학술 의료 및 외과 교육 | Cervico-Facial Surgery ENT Medical 레지던트(Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine 및 Provence-Alpes-Côte d'Azur 지역)프랑스
-
King Abdulaziz University모병측두하악 장애(TMD) | TMJ 통증 | 미술치료 | TMJ- Oral & amp; Maxillofacial Surgery | 윌크스 1과 2 | TMD 예술 통증 연구사우디 아라비아
Platelet-rich fibrin (PRF)에 대한 임상 시험
-
University of Rome Tor Vergata완전한
-
Baskent UniversityGazi University완전한
-
Dr. D. Y. Patil Dental College & Hospital완전한
-
Government Dental College and Research Institute...The Oxford Dental College, Hospital and Research Center, Bangalore, India완전한
-
Government Dental College and Research Institute...완전한